Found: 24
Select item for more details and to access through your institution.
High rate of profound clonal and renal responses with daratumumab treatment in heavily pre‐treated patients with light chain (AL) amyloidosis and high bone marrow plasma cell infiltrate.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 8, p. 900, doi. 10.1002/ajh.25828
- By:
- Publication type:
- Article
Peripheral neuropathy as clinical onset of monoclonal IgM/k‐related amyloidosis.
- Published in:
- Journal of the Peripheral Nervous System, 2023, v. 28, n. 2, p. 262, doi. 10.1111/jns.12540
- By:
- Publication type:
- Article
Treatment Induced Cytotoxic T-Cell Modulation in Multiple Myeloma Patients.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.682658
- By:
- Publication type:
- Article
A unique case of rapidly progressive glomerulonephritis following dexamethasone/bortezomib/thalidomide treatment for myeloma.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
Light-chain cardiac amyloidosis for the non-expert: pearls and pitfalls.
- Published in:
- Internal & Emergency Medicine, 2023, v. 18, n. 7, p. 1879, doi. 10.1007/s11739-023-03335-3
- By:
- Publication type:
- Article
Dealing With High-Risk AL Amyloidosis Patients: A Single Hematologic Center Experience.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 12, p. e970, doi. 10.1016/j.clml.2021.07.015
- By:
- Publication type:
- Article
Immune Profiling of Plasma Cell Dyscrasias Reveals a Therapy Related T-Cell Modulation in Multiple Myeloma Patients.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e87, doi. 10.1016/j.clml.2019.09.140
- By:
- Publication type:
- Article
Diffusion Weighted Whole Body MRI for Evaluation of Early Response in Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e118, doi. 10.1016/j.clml.2017.03.214
- By:
- Publication type:
- Article
Hyperammonemic Encephalopathy as Initial Presentation of Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e102, doi. 10.1016/j.clml.2017.03.185
- By:
- Publication type:
- Article
Infections in Multiple Myeloma: An Understimate Risk Factor of Comorbidity.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e30, doi. 10.1016/j.clml.2017.03.051
- By:
- Publication type:
- Article
Cytogenetic Impact on Lenalidomide Treatment in Relapsed/Refractory Multiple Myeloma: A Real-Life Evaluation.
- Published in:
- 2015
- By:
- Publication type:
- journal article
When Waldenström macroglobulinemia hits the kidney: Description of a case series and management of a "rare in rare" scenario.
- Published in:
- Cancer Reports, 2024, v. 7, n. 4, p. 1, doi. 10.1002/cnr2.2062
- By:
- Publication type:
- Article
Identification of the true hyperdiploid multiple myeloma subset by combining conventional karyotyping and FISH analysis.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Tixagevimab/Cilgavimab as pre-exposure prophylaxis against SARS-CoV-2 in patients with hematological malignancies.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1212752
- By:
- Publication type:
- Article
Effect of time to infusion of autologous stem cells (24 vs. 48 h) after high-dose melphalan in patients with multiple myeloma.
- Published in:
- European Journal of Haematology, 2012, v. 89, n. 2, p. 145, doi. 10.1111/j.1600-0609.2012.01795.x
- By:
- Publication type:
- Article
Low-risk identification in multiple myeloma using a new 14-gene model.
- Published in:
- European Journal of Haematology, 2012, v. 89, n. 1, p. 28, doi. 10.1111/j.1600-0609.2012.01792.x
- By:
- Publication type:
- Article
Alkaline phosphatase variation during carfilzomib treatment is associated with best response in multiple myeloma patients.
- Published in:
- European Journal of Haematology, 2011, v. 86, n. 6, p. 484, doi. 10.1111/j.1600-0609.2011.01602.x
- By:
- Publication type:
- Article
Severe infections unrelated to neutropenia impact on overall survival in multiple myeloma patients: results of a single centre cohort study.
- Published in:
- British Journal of Haematology, 2019, v. 186, n. 3, p. e13, doi. 10.1111/bjh.15849
- By:
- Publication type:
- Article
Effect of low‐dose bortezomib on bone formation in smouldering multiple myeloma.
- Published in:
- British Journal of Haematology, 2019, v. 184, n. 2, p. 308, doi. 10.1111/bjh.15095
- By:
- Publication type:
- Article
Lenalidomide in patients with chemotherapy-induced polyneuropathy and relapsed or refractory multiple myeloma: results from a single-centre prospective study.
- Published in:
- Journal of the Peripheral Nervous System, 2013, v. 18, n. 1, p. 19, doi. 10.1111/jns5.12002
- By:
- Publication type:
- Article
CK1α/RUNX2 Axis in the Bone Marrow Microenvironment: A Novel Therapeutic Target in Multiple Myeloma.
- Published in:
- Cancers, 2022, v. 14, n. 17, p. 4173, doi. 10.3390/cancers14174173
- By:
- Publication type:
- Article
Thromboembolic and Bleeding Events in Transthyretin Amyloidosis and Coagulation System Abnormalities: A Review.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 20, p. 6640, doi. 10.3390/jcm12206640
- By:
- Publication type:
- Article
Cardiac amyloidosis: a review of the literature and a practical approach for the clinicians.
- Published in:
- Italian Journal of Medicine, 2019, v. 13, n. 2, p. 73, doi. 10.4081/itjm.2019.1149
- By:
- Publication type:
- Article
Whole-body low-dose CT recognizes two distinct patterns of lytic lesions in multiple myeloma patients with different disease metabolism at PET/MRI.
- Published in:
- 2019
- By:
- Publication type:
- journal article